Selected Publications
"Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide"
J Biol Chem Vol. 285 Issue 52, 2009, pp.36007-36011.
"An anti-infective peptide that selectively modulates the innate immune response"
Nat Biotechnol, Vol. 25, 2007, pp.465-472.
Commercial opportunities in innate immunity
"Bad Bugs, No Drugs"
Infectious Diseases Society of America, 2005, 37pp.
"Number, Impact of Hospital-acquired Infections in Pennsylvania. Numbers Rise As Data Submission Improves"
Pennsylvania Health Care Cost Containment Council, 2006, 6pp.
"Evolving Epidemiology and Cost of Resistance to Antimicrobial Agents in Long-Term Care Facilities"
JAMDA, 2003, pp.S90-S99.
"Continuum conundrum"
BioCentury, Vol.14, 2006, pp.A1-A7.
Review Articles on Innate Immunity
"Aging and Innate Immunity"
Immunity, Vol. 24, 2006, pp.491-494.
"Alarmins: Chemotactic Activators of Immune Responses"
Curr Opin Immunol, Vol. 17. pp.359-365.
"Can innate immunity be enhanced to treat microbial infections?"
Nature Rev, Vol. 2, 2004, pp.497-504.
"Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense
Peptide LL-37"
J. Immunol, Vol. 176, 2006, pp.2455-2464.
"Susceptibility to infection in patients with neutropenia: the role of the innate immune system"
Brit J Haematol., Vol. 129, 2005, pp.713-722.
For copies of these articles, please send a request to: info@inimexpharma.com
